Ledger.Open graph →
SEC Form D · Amendment · filed June 19, 2020

Knopp Biosciences LLC

Offering
$30.0M
Sold
$14.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PITTSBURGH, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Chet Kapoor · San Francisco, CAExec · Director(General Partner) Tenzing Global Investors LLC · San Francisco, CAExec · Director · PromoterJames A. Mather · Pittsburgh, PAExecMark A. Kreston · Pittsburgh, PAExecKenneth J. Krebs · Columbus, OHDirector · PromoterMichael G. Purcell · Moorestown, NJExecSteven A. Dworetzky · Pittsburgh, PAExecMatthew Murphy · DENVER, COExecJeffrey S. Mccormick · Waltham, MADirectorBenjamin A. Gomez · Boston, MADirectorJames T. Merkel · Columbus, OHExec · Director · PromoterAndrei R. Bolshakov · Charlotte, NCExec · Director · PromoterThomas V. Petzinger, Jr · Pittsburgh, PADirector · PromoterThomas B. Pickens Iii · Austin, TXExecRichard Wang · San Francisco, CAExec · Director · PromoterStu Robbins · Lincoln, MAExecMichael E. Bozik · Pittsburgh, PAExec · Director · PromoterCalman A. Prussin · Pittsburgh, PAExec(Investment Manager) Tenzing Global Management LLC · San Francisco, CADirectorPaul Laviolette · Pompano Beach, FLExecPeter I. Mcmillan · Los Angeles, CAExecGregory T. Hebrank · Pittsburgh, PAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗